Octreotide as first-line treatment for women with metastatic breast cancer

被引：0
|
作者：
Ingle, JN
Kardinal, CG
Suman, VJ
Krook, JE
Hatfield, AK
机构：
[1] OCHSNER COMMUNITY CLIN ONCOL PROGRAM,NEW ORLEANS,LA 70121
[2] DULUTH COMMUNITY CLIN ONCOL PROGRAM,DULUTH,MN 55805
[3] COMMUNITY CLIN ONCOL PROGRAM,CARLE CANC CTR,URBANA,IL 61801
来源：
INVESTIGATIONAL NEW DRUGS | 1996年 / 14卷 / 02期
关键词：
octreotide; metastatic breast cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Octreotide is a synthetic somatostatin analogue which has shown inhibitory activity against human breast cancer cells in culture. Ten patients with metastatic breast cancer and no prior hormonal therapy exposure received octreotide at 150 mu g subcutaneously thrice daily. No objective responses were observed and the median time to treatment failure was short at 57 days.
引用
收藏
页码：235 / 237
页数：3
相关论文
共 50 条
  • [21] First-line Herceptin® monotherapy in metastatic breast cancer
    Vogel, CL
    Cobleigh, MA
    Tripathy, D
    Gutheil, JC
    Harris, LN
    Fehrenbacher, L
    Slamon, DJ
    Murphy, M
    Novotny, WF
    Burchmore, M
    Shak, S
    Stewart, SJ
    ONCOLOGY, 2001, 61 : 37 - 42
  • [22] First-line pemetrexed studied in metastatic breast cancer
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (09): : 1092 - +
  • [23] DURATION OF FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
    Gennari, Alessandra
    Provinciali, Nicoletta
    BREAST, 2015, 24 : S31 - S31
  • [24] Trastuzumab as first-line therapy for metastatic breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (07) : 776 - 776
  • [25] The 2007 Rome Forum on the Treatment of Breast Cancer: first-line treatment choices for metastatic breast cancer in Europe
    Conte, Pier Franco
    EJC SUPPLEMENTS, 2008, 6 (08): : 1 - 4
  • [26] The 2007 Rome Forum on the Treatment of Breast Cancer: first-line treatment choices for metastatic breast cancer in Europe
    Conte, Pier Franco
    EJC SUPPLEMENTS, 2008, 6 (04): : 1 - 4
  • [27] Tesetaxel: Activity of an oral taxane as first-line treatment in metastatic breast cancer
    Seidman, Andrew David
    Schwartzberg, Lee Steven
    O'Shaughnessy, Joyce
    D'Andrea, Gabriella
    Rubin, Peter
    Katz, Seth
    Danesi, Hassan
    Itri, Loretta
    Hudis, Clifford
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Treatability of patients with metastatic breast cancer after treatment by ixabepilone in first-line
    Thivat, E.
    Dalenc, F.
    Durando, X.
    Gladieff, L.
    Mouret-Reynier, M.
    Kwiatkowski, F.
    Deslandres, M.
    Chollet, P.
    Roche, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Gemcitabine plus vinorelbine as first-line treatment of metastatic breast cancer.
    Gokmen, E
    Sezgin, C
    Karabulut, B
    Vazquez, A
    Sanal, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 85S - 85S
  • [30] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    T Gamucci
    A M D'Ottavio
    E Magnolfi
    M Barduagni
    A Vaccaro
    I Sperduti
    L Moscetti
    F Belli
    L Meliffi
    British Journal of Cancer, 2007, 97 : 1040 - 1045
12345